What are the survival rates for metastatic Lymphoma

LymphomaMay 15, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case. No signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
Built by OpenCancer’s team of physician-scientists and cancer survivors.
Last updated May 15, 2026. Informational only — not a substitute for your oncology team.

Survival Rates for Metastatic Lymphoma

I appreciate this important question. However, I need to be direct with you: survival rates for metastatic lymphoma vary dramatically depending on several critical factors, and I don't have specific survival statistics in my available medical guidelines to share with you.

Why Survival Rates Are Complex for Lymphoma

Here's what matters for understanding your situation:

Type of Lymphoma Matters Most:

Hodgkin lymphoma and non-Hodgkin lymphoma (NHL) have very different outcomes
Within NHL, there are indolent (slow-growing) and aggressive subtypes with different prognoses
Specific subtypes like diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and mantle cell lymphoma each have different survival patterns

Other Critical Factors:

Whether the lymphoma is newly diagnosed or relapsed/refractory (has come back after treatment)
Your age and overall health
Specific biomarkers and genetic features of your lymphoma
How well the lymphoma responds to initial treatment
What treatment options are available to you

What's Changed Recently (Important!)

According to recent medical literature on CAR T-cell therapy for B-cell lymphoma, treatment options have expanded significantly. Anti-CD19 CAR T-cell therapy is now FDA-approved and considered standard of care for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma after 2 or more lines of therapy. This represents a major advancement that has improved outcomes for patients who previously had limited options.

What You Should Ask Your Oncologist

Rather than relying on general statistics, your doctor can provide personalized survival estimates based on YOUR specific situation:

What is the specific subtype and stage of my lymphoma? (This is the foundation for understanding prognosis)
What are the prognostic factors specific to my case? (Age, biomarkers, disease burden, etc.)
Based on my individual situation, what are realistic survival expectations?
What treatment options are available, and how do they affect survival outcomes?
Are there clinical trials I might be eligible for that could improve my outcomes?

Where to Find Reliable Information

For detailed, evidence-based information about lymphoma survival and treatment:

NCCN (National Comprehensive Cancer Network) Guidelines - provides detailed lymphoma-specific treatment recommendations
American Cancer Society - offers lymphoma-specific survival statistics and patient resources
National Cancer Institute (NCI) - provides comprehensive cancer information including prognosis data

Your oncology team has access to your specific pathology, imaging, and biomarker results—information that's essential for meaningful prognostic discussions.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation. No signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →